OpenEvidence
Company Overview
OpenEvidence is the leading medical information platform launched from the Mayo Clinic Platform Accelerate program. The platform features multimedia and clinical findings from prestigious sources including The New England Journal of Medicine and JAMA Network specialty journals.
Mission and Vision
Our mission is to organize and expand the world's collective medical knowledge to address the extreme challenge of information overload in medicine. OpenEvidence aggregates, synthesizes, and visualizes clinically relevant evidence to help physicians, medical researchers, and healthcare professionals make evidence-based decisions and improve patient outcomes.
Team and Advisors
The company is supported by a highly qualified team with members holding PhDs and advanced degrees from institutions such as Harvard, MIT, and Stanford. The team also includes notable medical advisors from leading institutions like Cedars-Sinai, Mayo Clinic, Cleveland Clinic, Harvard Medical School, and others.
Investors and Support
OpenEvidence is supported by prominent investors, including Sequoia, Google Ventures, Kleiner Perkins, Coatue, Thrive, Conviction, Greycroft, Breyer Capital, Mayo Clinic, and others.